Since you're a subscriber to this Bloomberg podcast, we thought you'd be interested in a six-episode

podcast called Targeting the Tuffest Diseases. Produced by Vertex Pharmaceuticals and Bloomberg Media

Studios. It explores the innovative tools, methods, and unique philosophy vertex

pharmaceuticals is using to search for treatments for some of

humanity's most challenging diseases. Here's a recent episode.

I'm so goal-oriented. I'm always just charging ahead. Like, we're going to get it done by any means possible.

Focused and fearless. That's the best way to describe Madison Carter. Those qualities have helped Madison

break a lot of important stories as an award-winning investigative reporter in Atlanta, Georgia.

She's investigated white nationalists,

political corruption, and the parole system. Those are stories that take a lot of guts to cover,

and Madison has done it all without hesitation. People will tell you, I go for everything. I say

everything that needs to be said. Like, I have no fear. Like, I don't have a lot to lose.

That fearlessness comes from a dark place.

It's because of my diabetes.

I'm like, I could die at any second.

Hi, I'm Jordan Gosspore, a member of the University of Southern California's Center for Health Journalism.

This is targeting the toughest diseases produced by Bloomberg Media Studios and Vertex Pharmaceuticals.

In this series, we look at some of humanity's most challenging diseases and how Vertex, a Boston-based biotech company, is using innovative tools, methods, and a unique philosophy

to search for treatments and cures.

Today, we're targeting type 1 diabetes, a chronic disease that affects more than 8 million

people around the world, a number that's expected to increase rapidly.

In the U.S. alone, approximately 1.4 million people, including nearly 170,000

...